scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0140-6736(00)04821-2 |
P698 | PubMed publication ID | 11425370 |
P50 | author | Fenella J. Kirkham | Q42251356 |
P2093 | author name string | J P Evans | |
R Lane | |||
A Wade | |||
D K Hewes | |||
M Prengler | |||
P2860 | cites work | Anatomical validation of middle cerebral artery position as identified by transcranial pulsed Doppler ultrasound | Q30495906 |
Diffusion and perfusion magnetic resonance imaging in childhood stroke. | Q30596801 | ||
Stroke in a cohort of patients with homozygous sickle cell disease | Q33981601 | ||
Sleep related upper airway obstruction and hypoxaemia in sickle cell disease | Q35628361 | ||
Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study | Q39471587 | ||
Subtle brain abnormalities in children with sickle cell disease: relationship to blood hematocrit. | Q42468878 | ||
Exacerbation of epilepsy by obstructive sleep apnoea | Q42911745 | ||
Prediction of adverse outcomes in children with sickle cell disease | Q44990679 | ||
Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome | Q47801435 | ||
Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography | Q47906551 | ||
The spectrum of epilepsy in sickle cell anemia | Q48130431 | ||
Sickle cell anemia and central nervous system infarction: a neuropathological study | Q48267058 | ||
Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease | Q48274342 | ||
Altitude and the nervous system | Q48423724 | ||
Abnormalities of the central nervous system in very young children with sickle cell anemia | Q48449499 | ||
Stroke associated with obstructive sleep apnea in a child with sickle cell anemia | Q48956949 | ||
Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia. | Q51370434 | ||
Is there a correlation between raised erythropoietin and thrombotic events in sickle-cell anaemia? | Q57591190 | ||
Perfusion magnetic resonance abnormalities in patients with sickle cell disease | Q58320460 | ||
Hypoxia, hyperoxia, ischemia, and brain necrosis | Q62803530 | ||
SNORING AND CEREBRAL INFARCTION | Q62853085 | ||
Upper airways obstruction and cerebrovascular accident in children with sickle cell anaemia | Q69372294 | ||
Effects of oxygen inhalation on endogenous erythropoietin kinetics, erythropoiesis, and properties of blood cells in sickle-cell anemia | Q71401973 | ||
Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler | Q73929295 | ||
P433 | issue | 9269 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sickle-cell disease | Q185034 |
hypoxemia | Q1479485 | ||
P304 | page(s) | 1656-1659 | |
P577 | publication date | 2001-05-01 | |
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease | |
P478 | volume | 357 |
Q59135916 | A ten year review of the sickle cell program in Muhimbili National Hospital, Tanzania |
Q34205726 | Abnormal autonomic cardiac response to transient hypoxia in sickle cell anemia. |
Q36286034 | Abnormal transcranial Döppler ultrasonography in children with sickle cell disease |
Q89351542 | Adenotonsillectomy in children with sickle cell disease and obstructive sleep apnea |
Q38089946 | Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia. |
Q91639061 | American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease |
Q52030668 | An exploratory study of physiological correlates of neurodevelopmental delay in infants with sickle cell anaemia. |
Q37413923 | An observational study of children with sickle cell disease in Kilifi, Kenya |
Q35170873 | Anaesthetic management of the child with sickle cell disease |
Q48099211 | Assessment of sleep-related disorders in children with sickle cell disease |
Q37246765 | Auto-adjusting positive airway pressure in children with sickle cell anemia: results of a phase I randomized controlled trial |
Q57827837 | BOLD delay times using group delay in sickle cell disease |
Q42451901 | Brain Perfusion Impairment in Neurologically Asymptomatic Adult Patients with Sickle-Cell Disease Shown by Voxel-Based Analysis of SPECT Images |
Q36761420 | Central nervous system complications of sickle cell disease in children: an overview |
Q37941865 | Cerebral infarction in children with sickle cell disease: a concise overview |
Q92530646 | Cerebral oxygen metabolism in adults with sickle cell disease |
Q36501408 | Cerebral tissue hemoglobin saturation in children with sickle cell disease |
Q38719970 | Chronic Pulmonary Complications of Sickle Cell Disease |
Q40147937 | Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective study. |
Q35785748 | Clinical correlates of steady-state oxyhaemoglobin desaturation in children who have sickle cell disease |
Q48255058 | Clinical practice guideline: Polysomnography for sleep-disordered breathing prior to tonsillectomy in children |
Q37033939 | Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies. |
Q49949564 | Comorbid obstructive sleep apnea and increased risk for sickle cell disease morbidity |
Q35843105 | Daytime pulse oximeter measurements do not predict incidence of pain and acute chest syndrome episodes in sickle cell anemia |
Q36925624 | Daytime steady-state haemoglobin desaturation is a risk factor for overt stroke in children with sickle cell anaemia. |
Q36065185 | Defining stroke risk in children with sickle cell anaemia |
Q92261111 | Does Obstructive Sleep Apnea Increase Cognitive Deficits in Pediatric Sickle Cell Disease? |
Q44484416 | Effects of adenotonsillectomy on polysomnographic parameters in children with sickle cell disease |
Q50201524 | Effects of hydroxyurea on blood rheology in sickle cell anemia: A two-years follow-up study. |
Q37848086 | Executive summary of respiratory indications for polysomnography in children: an evidence-based review |
Q90602349 | Genetic, laboratory and clinical risk factors in the development of overt ischemic stroke in children with sickle cell disease |
Q43723150 | Graph Lasso-Based Test for Evaluating Functional Brain Connectivity in Sickle Cell Disease. |
Q37251490 | Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association |
Q37332183 | Haemoglobin oxygen saturation is a determinant of cerebral artery blood flow velocity in children with sickle cell anaemia |
Q48304119 | Haemoglobin oxygen saturation, leucocyte count and lactate dehydrogenase are predictors of elevated cerebral blood flow velocity in Nigerian children with sickle cell anaemia. |
Q36830041 | Hematological and Genetic Predictors of Daytime Hemoglobin Saturation in Tanzanian Children with and without Sickle Cell Anemia |
Q64092382 | Hemodynamic provocation with acetazolamide shows impaired cerebrovascular reserve in adults with sickle cell disease |
Q61631727 | Home Oxygen Therapy for Children. An Official American Thoracic Society Clinical Practice Guideline |
Q30945117 | How I manage cerebral vasculopathy in children with sickle cell disease |
Q47740914 | How I manage sickle cell patients with high transcranial doppler results. |
Q35185431 | Hydroxyurea Improves Oxygen Saturation in Children With Sickle Cell Disease |
Q48612035 | Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology |
Q38205407 | Hypoxia and inflammation in children with sickle cell disease: implications for hippocampal functioning and episodic memory. |
Q31043815 | Hypoxic adaptation during development: relation to pattern of neurological presentation and cognitive disability |
Q36914340 | Increased von Willebrand factor antigen and high molecular weight multimers in sickle cell disease associated with nocturnal hypoxemia. |
Q36293892 | Low daytime pulse oximetry reading is associated with nocturnal desaturation and obstructive sleep apnea in children with sickle cell anemia |
Q48193272 | Low flow nocturnal oxygen therapy does not suppress haemoglobin levels or increase painful crises in sickle cell disease. |
Q31116644 | Magnetic resonance imaging in pediatric sickle cell anemia |
Q39141859 | Mortality, asthma, smoking and acute chest syndrome in young adults with sickle cell disease |
Q51970597 | Neurobehavioral impact of sickle cell disease in early childhood. |
Q37812519 | Neuroimaging in assessment of risk of stroke in children with sickle cell disease |
Q47853908 | Nocturnal hemoglobin desaturation is associated with reticulocytosis in adults with sickle cell disease and is independent of obstructive sleep apnea |
Q47424061 | Nocturnal oxyhemoglobin desaturation and arteriopathy in a pediatric sickle cell disease cohort. |
Q36010795 | Non-invasive measurements of carboxyhemoglobin and methemoglobin in children with sickle cell disease |
Q34296032 | Obstructive sleep apnea and sickle cell anemia |
Q47642462 | Overnight auto-adjusting continuous airway pressure + standard care compared with standard care alone in the prevention of morbidity in sickle cell disease phase II (POMS2b): study protocol for a randomised controlled trial |
Q78493256 | Oxygen saturation and hemoglobin A content in patients with sickle cell disease undergoing erythrocytapheresis |
Q46405019 | Pain, coping, and sleep in children and adolescents with sickle cell disease. |
Q35026922 | Parent education and biologic factors influence on cognition in sickle cell anemia |
Q57636157 | Pathophysiology and physical activity in patients with sickle cell anemia |
Q36483981 | Pathophysiology and treatment of stroke in sickle-cell disease: present and future |
Q39694415 | Performance of a digital PCO2/SPO2 ear sensor |
Q38712594 | Periodic limb movement in sleep and sickle cell disease: a neglected association? |
Q35219737 | Peripheral vasoconstriction and abnormal parasympathetic response to sighs and transient hypoxia in sickle cell disease. |
Q48038108 | Physical activity level is not a determinant of autonomic nervous system activity and clinical severity in children/adolescents with sickle cell anemia: A pilot study |
Q31043811 | Physiological correlates of intellectual function in children with sickle cell disease: hypoxaemia, hyperaemia and brain infarction |
Q38942105 | Prevalence of Developmental Delay and Contributing Factors Among Children With Sickle Cell Disease |
Q58319619 | Prevention of Morbidity in sickle cell disease--qualitative outcomes, pain and quality of life in a randomised cross-over pilot trial of overnight supplementary oxygen and auto-adjusting continuous positive airways pressure (POMS2a): study protocol f |
Q37404519 | Prospective evaluation of haemoglobin oxygen saturation at rest and after exercise in paediatric sickle cell disease patients |
Q27027066 | Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease |
Q36161364 | Psychological complications in sickle cell disease |
Q34141912 | Pulmonary Complications of Hemoglobinopathies |
Q26824724 | Recommendations for long-term home oxygen therapy in children and adolescents |
Q39494212 | Reticulocyte count is the most important predictor of acute cerebral ischemia and high-risk transcranial Doppler in a newborn cohort of 395 children with sickle cell anemia |
Q34401239 | Risk factors for high cerebral blood flow velocity and death in Kenyan children with Sickle Cell Anaemia: role of haemoglobin oxygen saturation and febrile illness |
Q33690218 | Severe nocturnal and postexercise hypoxia in children and adolescents with sickle cell disease |
Q37527752 | Sickle Cell Disease with Cyanotic Congenital Heart Disease: Long-Term Outcomes in 5 Children |
Q37008399 | Sickle cell anemia-associated pulmonary arterial hypertension |
Q36715984 | Sickle cell disease in Africa: burden and research priorities |
Q34023071 | Sickle cell disease: selected aspects of pathophysiology. |
Q34733113 | Sickle cell disease: the neurological complications |
Q28287003 | Sickle-cell disease |
Q34469224 | Sleep disturbance, depression and pain in adults with sickle cell disease |
Q35685589 | Sleep problems in children with common medical disorders. |
Q37196718 | Sleep-disordered breathing and nocturnal hypoxemia in young adults with sickle cell disease |
Q47656335 | Sleep-disordered breathing in patients with sickle cell disease |
Q36282445 | Stability of polysomnography for one year and longer in children with sickle cell disease |
Q39055426 | Stroke and Hypertension in Children and Adolescents. |
Q58320277 | Stroke and cerebrovascular disease in childhood |
Q53636732 | Stroke in Children with Sickle Cell Disease. |
Q30650303 | Stroke in patients with sickle cell disease |
Q48239133 | The association of oral hydroxyurea therapy with improved cognitive functioning in sickle cell disease |
Q37292454 | The autonomic nervous system and ischemic stroke: a reciprocal interdependence. |
Q89553838 | The effect of obstructive sleep apnea syndrome on serum S100B and NSE levels: a systematic review and meta-analysis of observational studies |
Q37955226 | The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease |
Q36428729 | Therapeutic approaches and advances in pediatric stroke |
Q36811118 | Therapy insight: stroke risk and its management in patients with sickle cell disease. |
Q44928119 | Transcranial Doppler ultrasonography in children with sickle cell anemia: Clinical and laboratory correlates for elevated blood flow velocities |
Q36165026 | Upper airway lymphoid tissue size in children with sickle cell disease |
Q34157612 | Variability of pulse oximetry measurement over 1 year in children with sickle cell disease depends on initial oxygen saturation measurement |
Q93047390 | Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework |
Q90749587 | Vaso-Occlusion in Sickle Cell Disease: Is Autonomic Dysregulation of the Microvasculature the Trigger? |
Q27012863 | Wheezing in children with sickle cell disease |
Q55052815 | White matter integrity and processing speed in sickle cell anemia. |
Search more.